Holen Sie sich die Stockscreener-App
5.85
1.60%
-0.095
Handel nachbörslich:
5.88
0.03
+0.51%
Tenax Therapeutics Inc Aktie (TENX) Neueste Nachrichten
How Tenax Therapeutics Inc. stock performs during market volatilityWeekly Double Return List - Newser
Why Tenax Therapeutics Inc. stock attracts strong analyst attentionMarket Timing Advice - Newser
What makes Tenax Therapeutics Inc. stock price move sharplyFree High-Accuracy Stock Picks - Newser
How PTC Therapeutics Inc. stock performs during market volatilityDaily Stock Radar - Newser
(TENX) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
(TENX) Investment Analysis - news.stocktradersdaily.com
(TENX) On The My Stocks Page - news.stocktradersdaily.com
Tenax Therapeutics Approves Officer Exculpation Amendment - TipRanks
Two Sigma Investments LP Acquires Shares of 13,521 Tenax Therapeutics, Inc. (NASDAQ:TENX) - Defense World
Millennium Management LLC Acquires New Holdings in Tenax Therapeutics, Inc. (NASDAQ:TENX) - Defense World
When (TENX) Moves Investors should Listen - news.stocktradersdaily.com
Where are the Opportunities in (TENX) - news.stocktradersdaily.com
Tectonic, Tenax, others aim for shift in heart failure - BioWorld MedTech
Tenax Therapeutics Reports Increased Losses Amid Strategic Investments - TipRanks
Roth Capital Issues Negative Forecast for TENX Earnings - Defense World
William Blair Cuts Earnings Estimates for Tenax Therapeutics - Defense World
Leerink Partnrs Brokers Boost Earnings Estimates for TENX - Defense World
What is William Blair’s Estimate for TENX FY2028 Earnings? - Defense World
Roth Capital Has Bearish Forecast for TENX FY2028 Earnings - Defense World
Tenax Therapeutics (NASDAQ:TENX) Now Covered by StockNews.com - Defense World
Tenax Therapeutics: Q1 Earnings Snapshot - Bluefield Daily Telegraph
Tenax Therapeutics (TENX) Projects Funding Through 2027 | TENX S - GuruFocus
Analyst Adjusts Tenax Therapeutics (TENX) Price Target, Maintains Buy Rating | TENX Stock News - GuruFocus
Tenax Therapeutics (TENX) Advances Phase 3 Studies in 2025 | TEN - GuruFocus
Tenax Therapeutics Inc Reports Q1 2025 Net Loss of $10.4 Million Amid Rising R&D and Administrative Expenses - GuruFocus
Tenax Therapeutics (TENX) Projects Funding Through 2027 | TENX Stock News - GuruFocus
Tenax Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Tenax Advances Breakthrough PH-HFpEF Treatment: Phase 3 Trial Updates and $111M War Chest Revealed - Stock Titan
Tenax Therapeutics: A High-Reward Play on a $B Market’s First-in-Class Breakthrough - AInvest
Tenax Therapeutics (TENX) Projected to Post Earnings on Tuesday - Defense World
(TENX) Technical Data - news.stocktradersdaily.com
Tenax Therapeutics (NASDAQ:TENX) Coverage Initiated by Analysts at StockNews.com - Defense World
Geode Capital Management LLC Boosts Stock Position in Tenax Therapeutics, Inc. (NASDAQ:TENX) - Defense World
Tenax Therapeutics (NASDAQ:TENX) Coverage Initiated at StockNews.com - Defense World
Form SC 13G/AStatement of Beneficial Ownership by Certain Investors: [Amend] - ADVFN
SEC Form DEF 14A filed by Tenax Therapeutics Inc. - Quantisnow
Form DEF 14A TENAX THERAPEUTICS, INC. For: Apr 24 - StreetInsider
Tenax Therapeutics Advances Cardiopulmonary Therapies - TipRanks
Tenax Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference - The Globe and Mail
Oxygen Biotherapeutics, Inc. : Oxygen Biotherapeutics Announces Third Quarter FY2013 Financial Results Conference Call and Webcast - marketscreener.com
Teanx Therapeutics plans secondary offering - MSN
Tenax: Phase 3 Heart Failure Program Continues With 2 Key Catalysts - Seeking Alpha
Tenax Therapeutics (TENX) Files Prospectus for Stock Resale - GuruFocus
3.40%
2.49%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):